
Home » FDA RESTARTS REVIEW OF ENTEREG
FDA RESTARTS REVIEW OF ENTEREG
Pharmaceutical companies Adolor Corp. and GlaxoSmithKline Plc on Wednesday said regulators will resume reviewing the companies' application for a drug to treat intestinal obstructions after new data from a study reaffirmed the drug's effectiveness.
Business Week
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
08Sep
-
13Sep
-
14Sep
-
15Sep
-
20Sep
-
21Sep